3692 HANSON
1. Behavior, abbreviation EMA35 test and Horizontal Line
2. The stock chart is stronger than the INDEX
3. Operating results grow in the second half of 2023 after partnering with allies, allowing sales to grow rapidly.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11 USD
609.95 M USD
1.71 B USD
1.23 B
About Hansoh Pharmaceutical Group Company Limited
Sector
Industry
CEO
Hui Juan Zhong
Website
Headquarters
Shanghai
Founded
2015
ISIN
KYG549581067
FIGI
BBG00Z8394F3
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, CNS diseases; metabolic and other diseases. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS228414433
Hansoh Pharmaceutical Group Company Limited 0.0% 22-JAN-2026Yield to maturity
—
Maturity date
Jan 22, 2026
See all HNSPF bonds
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
4.07%
Market value
77.29 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
3.27%
Market value
20.79 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
4.18%
Market value
17.26 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of HNSPF is 5.00 USD — it has increased by 10.86% in the past 24 hours. Watch Hansoh Pharmaceutical Group Co Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hansoh Pharmaceutical Group Co Ltd. stocks are traded under the ticker HNSPF.
We've gathered analysts' opinions on Hansoh Pharmaceutical Group Co Ltd. future price: according to them, HNSPF price has a max estimate of 6.44 USD and a min estimate of 4.61 USD. Watch HNSPF chart and read a more detailed Hansoh Pharmaceutical Group Co Ltd. stock forecast: see what analysts think of Hansoh Pharmaceutical Group Co Ltd. and suggest that you do with its stocks.
HNSPF reached its all-time high on Dec 18, 2024 with the price of 5.58 USD, and its all-time low was 1.50 USD and was reached on Jan 31, 2024. View more price dynamics on HNSPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HNSPF stock is 9.80% volatile and has beta coefficient of 0.61. Track Hansoh Pharmaceutical Group Co Ltd. stock price on the chart and check out the list of the most volatile stocks — is Hansoh Pharmaceutical Group Co Ltd. there?
Today Hansoh Pharmaceutical Group Co Ltd. has the market capitalization of 32.71 B, it has decreased by −1.18% over the last week.
Yes, you can track Hansoh Pharmaceutical Group Co Ltd. financials in yearly and quarterly reports right on TradingView.
Hansoh Pharmaceutical Group Co Ltd. is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
HNSPF earnings for the last half-year are 0.07 USD per share, whereas the estimation was 0.05 USD, resulting in a 47.22% surprise. The estimated earnings for the next half-year are 0.03 USD per share. See more details about Hansoh Pharmaceutical Group Co Ltd. earnings.
Hansoh Pharmaceutical Group Co Ltd. revenue for the last half-year amounts to 1.04 B USD, despite the estimated figure of 916.11 M USD. In the next half-year revenue is expected to reach 1.05 B USD.
HNSPF net income for the last half-year is 428.84 M USD, while the previous report showed 229.81 M USD of net income which accounts for 86.60% change. Track more Hansoh Pharmaceutical Group Co Ltd. financial stats to get the full picture.
Hansoh Pharmaceutical Group Co Ltd. dividend yield was 1.95% in 2024, and payout ratio reached 42.07%. The year before the numbers were 1.35% and 34.83% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 10, 2025, the company has 8.99 K employees. See our rating of the largest employees — is Hansoh Pharmaceutical Group Co Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hansoh Pharmaceutical Group Co Ltd. EBITDA is 665.40 M USD, and current EBITDA margin is 35.51%. See more stats in Hansoh Pharmaceutical Group Co Ltd. financial statements.
Like other stocks, HNSPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hansoh Pharmaceutical Group Co Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hansoh Pharmaceutical Group Co Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hansoh Pharmaceutical Group Co Ltd. stock shows the buy signal. See more of Hansoh Pharmaceutical Group Co Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.